Active Ingredient History
Mirasol may refer to: Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acidosis, Lactic (Phase 4)
Acquired Immunodeficiency Syndrome (Phase 4)
Alcoholism (Phase 2)
Alcohol Withdrawal Delirium (Phase 2/Phase 3)
Amyotrophic Lateral Sclerosis (Phase 1)
Arthritis, Rheumatoid (Phase 1/Phase 2)
Autoimmune Diseases (Phase 1/Phase 2)
Burning Mouth Syndrome (Early Phase 1)
Burns, Chemical (Phase 1/Phase 2)
Central Serous Chorioretinopathy (Phase 2)
Chronic Pain (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Compliance (Phase 2)
Corneal Diseases (Phase 4)
Corneal Neovascularization (Phase 2/Phase 3)
Corneal Ulcer (Phase 2/Phase 3)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 3)
Crohn Disease (Phase 3)
Deficiency Diseases (Phase 2/Phase 3)
Delayed Emergence from Anesthesia (Phase 2)
Delirium (Phase 2)
Dermatology (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetic Neuropathies (Phase 3)
Dilatation, Pathologic (Phase 3)
Esophageal Mucosa (Early Phase 1)
Fatigue (Phase 4)
Gastric Antral Vascular Ectasia (Phase 2)
Gastrointestinal Microbiome (Phase 2)
Head Injuries, Closed (Phase 3)
Healthy Volunteers (Phase 1)
Hematologic Diseases (Phase 3)
Hepatitis B, Chronic (Phase 4)
HIV Infections (Phase 4)
Infections (Phase 3)
Ischemic Stroke (Phase 2)
Keratectomy (Phase 3)
Keratitis (Phase 4)
Keratoconus (Phase 4)
Lipodystrophy (Phase 4)
Lupus Erythematosus, Systemic (Phase 1/Phase 2)
Magnesium Deficiency (Phase 2/Phase 3)
Malnutrition (Early Phase 1)
Myalgia (Early Phase 1)
Mycobacterium tuberculosis (Phase 3)
Myocardial Infarction (Phase 2)
Myopia (Phase 2)
Neoplasms (Phase 3)
Neurocognitive Disorders (Phase 2)
Nutrition Disorders (Phase 2)
Obesity (Phase 4)
Oral Ulcer (Phase 3)
Pemphigoid, Benign Mucous Membrane (Phase 1/Phase 2)
Psoriasis (Phase 2)
Refractive Errors (Phase 2)
Sports Medicine (Phase 2)
Steatitis (Phase 4)
Stevens-Johnson Syndrome (Phase 1/Phase 2)
Stomach Neoplasms (Early Phase 1)
Stroke (Phase 3)
Ureteral Diseases (Early Phase 1)
Uterine Cervical Neoplasms (Phase 1/Phase 2)
Wernicke Encephalopathy (Phase 2/Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue